Receive Discount Codes straight to your inbox!* (Conditions apply)

Discount code Subs form

By logging in or enrolling, you agree to have read our Privacy Policy and Ts & Cs, and to receive weekly email updates with new course content, materials, and valuable learning resources. Feel free to call or text us at 0432 894 232 for any assistance.

Chapter 1 · Cardiovascular Medicine · Lesson 5

Pericarditis, myocarditis and pericardial effusion

Fellowship-level theory for the RACGP AKT and KFP, built on the 2025 ESC myocarditis and pericarditis guideline and Australian therapeutic guidance.

Next scheduled review: November 2027 Reading time ≈ 60 min
Guideline watch — read this first

There is no stand-alone Australian guideline for pericardial disease or myocarditis. Australian practice follows Therapeutic Guidelines and the European Society of Cardiology. The 2025 ESC guideline for the management of myocarditis and pericarditis replaced the 2015 ESC pericardial guideline. It treats the two conditions as one spectrum, the inflammatory myopericardial syndrome (IMPS), and makes return to exercise individualised rather than a fixed ban.1 The core outpatient treatment of acute pericarditis (an NSAID or aspirin plus colchicine) is unchanged.

What has changed recently
  • Aug 2025: ESC myocarditis and pericarditis guideline: the IMPS concept; colchicine “integral” to first-line therapy; IL-1 inhibitors for recurrent pericarditis with raised CRP that fails standard therapy; initial exercise restriction of about 1 month, then individualised.1
  • 2021–2023: recognition of myocarditis and pericarditis after mRNA COVID-19 vaccines, mostly in young males after the second dose; vaccine advice in the Australian Immunisation Handbook.9
  • 2021: the IL-1 inhibitor rilonacept reduced recurrences in recurrent pericarditis (RHAPSODY trial).12
Studying from old notes?

Each statement below was standard teaching some years ago. Decide whether it is still true before you tap.

Treat a first episode of pericarditis with an NSAID alone; keep colchicine for recurrences.
No longer true. Colchicine is added from the first episode, for 3 months, because it halves the recurrence rate. See 3.4.
Corticosteroids are a good first-line choice for acute pericarditis.
No longer true. Steroids increase the risk of recurrence. They are second-line (failure or contraindication of NSAIDs, pregnancy after 20 weeks, specific causes), at low to moderate doses with a slow taper. See 3.4.
After myocarditis or pericarditis, everyone stops competitive sport for exactly 6 months.
No longer true. The 2025 ESC guideline recommends an initial restriction (about 1 month) and then an individualised return based on symptoms, inflammation markers, LV function, arrhythmias and imaging. See 4.3.

Cold-start check

Answer these questions before you read the lesson. Getting some wrong is the point: attempting questions before studying helps you remember the answers afterwards, and your score tells you where to spend your time.

1. Which ECG feature most strongly favours pericarditis over an occlusion MI?

Widespread PR depression, no reciprocal ST depression (except in aVR and V1). Read 3.2 Diagnosis and the ECG →

2. For a first episode of acute pericarditis, how long is colchicine given?

3 months (at least 6 months for a recurrence). Read 3.4 Treatment →

3. Pulsus paradoxus is an inspiratory fall in systolic BP of more than:

10 mmHg. A sign of cardiac tamponade (also severe asthma). Read 5.2 Tamponade →

4. Which anti-inflammatory is preferred for pericarditis after a myocardial infarction?

Aspirin. Other NSAIDs and steroids may impair healing of the infarct; aspirin is already part of antiplatelet therapy. Read 3.6 Special situations →

5. Clozapine-induced myocarditis most often occurs:

In the first 4 weeks. Monitor troponin and CRP weekly during this period. Read 4.1 Causes of myocarditis →

Your score: / 5

ScoreWhat to do
5 / 5Strong start. Skim the key takeaways, then go straight to the self-check questions.
3–4 / 5Read the sections linked from the questions you missed, then do the self-check.
0–2 / 5Work through the whole lesson. Check the old-notes box above as well.

Learning objectives

  1. Diagnose acute pericarditis and distinguish it from an occlusion MI on the ECG.
  2. Decide which patients can be managed at home and treat them correctly.
  3. Recognise and manage recurrent pericarditis and pericarditis in special situations.
  4. Recognise myocarditis, including drug- and vaccine-related cases, and advise on return to activity.
  5. Recognise pericardial effusion, tamponade and constriction, and act on them.

How this is examined

  • AKT: ECG differences, colchicine dose and duration, high-risk features, pulsus paradoxus, post-MI pericarditis, clozapine monitoring.
  • KFP: diagnosis from an ECG image, “list your pharmacological management”, red flags for admission, follow-up advice.
  • Common trap: treating pericarditis as an MI (or the reverse), giving two NSAIDs at once, or omitting colchicine.
★ Study-priority stars

Every section carries a GP Institute study-priority rating. It is our editorial judgement, based on the RACGP curriculum, how heavily current Australian guidelines emphasise the topic, patient safety, recent changes, and the themes in published RACGP exam reports. It is not an official RACGP weighting, and any topic can be examined.

RatingWhat it means for your study
★★★★Must know. Core, frequently examined, safety-critical or recently changed. Know it cold, without notes.
★★★☆High yield. Commonly tested; know the thresholds, drugs and next steps.
★★☆☆Know the principles. Understand the reasoning; detailed numbers are less likely to be asked.
★☆☆☆Background. Read once for context.

1. Why it matters ★☆☆☆

Acute pericarditis accounts for a small but important share of chest pain presentations. Most cases are viral or idiopathic and settle with treatment that a GP can start. The difficulty is that pericarditis, myocarditis and occlusion MI can look alike: all three cause chest pain, ST elevation and sometimes a troponin rise. Getting it wrong in one direction leads to unnecessary fibrinolysis or angiography; in the other, to a missed infarct. A RACGP KFP report described exactly this error: candidates misdiagnosed acute pericarditis on an ECG as an MI and managed it wrongly.6

Recurrence is the main long-term problem. Up to a third of patients have a recurrence, and correct treatment of the first episode, especially colchicine for 3 months and avoiding early steroids, is the best prevention.1,2

2. The pericardium and definitions ★★☆☆

The pericardium is a two-layered sac (fibrous parietal and serous visceral layers) containing up to about 50 mL of fluid. Inflammation causes pain and friction (pericarditis); fluid accumulation causes an effusion; rapid or large accumulation raises intrapericardial pressure and compresses the heart (tamponade); chronic scarring stops the heart filling (constriction). Inflammation often spreads to the adjacent myocardium (myopericarditis), which is why the 2025 ESC guideline groups the conditions as the inflammatory myopericardial syndrome.1

2.1 Definitions by time course and myocardial involvement ★★★☆

Table 1. Pericarditis terminology
TermDefinition
Acute pericarditisFirst episode, usually settling within 4–6 weeks
IncessantSymptoms lasting more than 4–6 weeks without remission
RecurrentA new episode after a symptom-free interval of 4–6 weeks or more
ChronicLasting more than 3 months
MyopericarditisPericarditis with myocardial involvement (troponin rise) but normal LV function
Perimyocarditis / myocarditisPredominant myocardial involvement, often with LV dysfunction

Definitions from the ESC guidelines.1,2

3. Acute pericarditis ★★★★

3.1 Causes ★★★☆

Table 2. Causes of pericarditis in Australia
GroupExamplesClues
Idiopathic or viral (most cases)Coxsackie, echovirus, influenza, SARS-CoV-2Preceding viral illness; young adults; men more than women
Post-cardiac injuryEarly post-MI pericarditis, Dressler syndrome (weeks later), post-pericardiotomy, after PCI or ablationRecent cardiac event or procedure
Autoimmune and inflammatorySLE, rheumatoid arthritis, systemic sclerosis, vasculitis, familial Mediterranean feverJoint, skin or kidney features; autoantibodies
NeoplasticLung and breast cancer, lymphoma, melanoma metastasesWeight loss, large or recurrent effusion, known cancer
BacterialTuberculosis; purulent (staphylococcal, streptococcal, pneumococcal)Fever >38°C, subacute course, migrant or remote community background, immunosuppression
MetabolicUraemia, hypothyroidism (effusion)Kidney failure; dialysis
Drugs and radiationHydralazine, isoniazid, procainamide (drug-induced lupus); immune checkpoint inhibitors; chest radiotherapyMedicine history

3.2 Diagnosis and the ECG ★★★★

The diagnosis needs at least two of four criteria: typical chest pain (sharp, pleuritic, better sitting forward, worse lying flat); a pericardial friction rub; characteristic ECG changes (widespread ST elevation or PR depression); and a new or worsening pericardial effusion. Raised CRP, imaging evidence of pericardial inflammation (CT or cardiac MRI) and fever support the diagnosis.1,2 The rub is heard in only about a third of patients and comes and goes, so listen more than once with the patient leaning forward.

↔ Swipe sideways to see the whole figure

Schematic ECG complexes comparing acute pericarditis (concave ST elevation with PR depression) with occlusion myocardial infarction (convex ST elevation with reciprocal depression) Acute pericarditis Occlusion MI (ACOMI) PR depression Concave (“smiley”) ST Convex (dome) ST Widespread, not in one coronary territory No reciprocal depression (except aVR, V1) No Q waves; T inversion only after ST settles Confined to one coronary territory Reciprocal ST depression in opposite leads Q waves may develop; PR segment normal
Figure 1. Schematic ECG features of pericarditis and occlusion MI. When in doubt, treat as possible ACS and transfer: the cost of missing an infarct is higher.2,3
Table 3. Investigations in suspected pericarditis
TestPurposeTypical finding
ECGDiagnosis; exclude ACOMIWidespread concave ST elevation and PR depression; later T-wave inversion; may be normal
CRP (and ESR)Supports diagnosis; guides treatment lengthRaised; normalisation guides tapering
TroponinMyocardial involvementRaised in about a third: myopericarditis
FBC, UEC, LFTsBaseline before NSAIDs and colchicine; uraemia—
EchocardiographyAll patients: effusion, tamponade, LV functionOften normal or small effusion
Chest X-rayOther causes; large effusionUsually normal
Targeted testsWhen a specific cause is suspectedTSH, ANA, IGRA or TB tests, blood cultures, HIV, CT for malignancy

3.3 Who can be managed at home? ★★★★

Most patients without high-risk features can be managed as outpatients, provided the diagnosis is secure and an echocardiogram can be arranged promptly. Patients with any major high-risk feature should be admitted.2

Table 4. High-risk features in acute pericarditis
Major (admit)Minor (consider admission)
Fever >38°C
Subacute onset (over days to weeks)
Large effusion (diastolic echo-free space >20 mm)
Cardiac tamponade
No response to NSAIDs after 1 week
Myopericarditis (raised troponin)
Immunosuppression
Trauma
Oral anticoagulant therapy
Figure 2. Acute pericarditis in general practice.1,2

3.4 Treatment ★★★★

Table 5. Treatment of acute pericarditis (adults)
DrugDoseDuration and notes
Ibuprofen or600 mg three times daily with food1–2 weeks, then taper over a few weeks guided by symptoms and CRP
Aspirin750–1000 mg three times dailyPreferred after MI or if already on antiplatelet therapy; same duration and taper
Colchicine (added from the start)500 micrograms once daily if <70 kg; twice daily if ≥70 kg3 months for a first episode; at least 6 months for recurrence. No taper needed. Reduce dose in older people and kidney impairment; interactions with clarithromycin, azoles, verapamil, diltiazem, some statins
PPIStandard doseWhile on high-dose NSAID or aspirin
Prednisolone (second line)Low to moderate dose (0.2–0.5 mg/kg daily)Only if NSAIDs fail or are contraindicated, or for specific causes; taper slowly; increases recurrence

Doses from the ESC guidelines; check current Therapeutic Guidelines.1,2,4 Choose one NSAID: never combine two. Advise rest from strenuous activity until symptoms resolve and CRP normalises (section 4.3). In the ICAP trial, adding colchicine to standard anti-inflammatory therapy roughly halved the rate of incessant or recurrent pericarditis.11

Exam pearl

The full answer to “pharmacological management of acute idiopathic pericarditis” has three parts: one NSAID (or aspirin) at a high dose with a taper, colchicine for 3 months (dose by weight), and a PPI. Steroids, two NSAIDs at once, antibiotics, anticoagulants and fibrinolysis all score zero.

3.5 Recurrent pericarditis ★★★☆

Recurrences are usually immune-mediated rather than new infections. Common reasons are stopping treatment too early, tapering too quickly, omitting colchicine and early steroid use. Treat with the NSAID or aspirin again plus colchicine for at least 6 months, tapering the NSAID only when CRP is normal. Patients who fail this, or become steroid-dependent, should see a cardiologist. In patients with raised CRP whose recurrent pericarditis fails standard treatment, the 2025 ESC guideline recommends IL-1 inhibitors (anakinra, rilonacept); other options are azathioprine and IV immunoglobulin.1,12 These are specialist treatments; check access and PBS status.

3.6 Special situations ★★★☆

Table 6. Pericarditis in special situations
SituationWhat differs
Early post-MI pericarditis (days 1–3) and Dressler syndrome (weeks later)Aspirin is the anti-inflammatory of choice; avoid other NSAIDs and steroids early after MI (impaired scar healing, more cardiac events). Colchicine can be added
Post-pericardiotomy and post-procedureAspirin or NSAID plus colchicine; specialist liaison
PregnancyNSAIDs and high-dose aspirin can be used before 20 weeks but should be avoided after 20 weeks; low-dose prednisolone is the option later in pregnancy. Colchicine: specialist advice. Ibuprofen is compatible with breastfeeding
ChildrenIbuprofen (weight-based); avoid aspirin (Reye syndrome); colchicine at weight-based doses
Kidney failureUraemic pericarditis: intensify dialysis; avoid NSAIDs; colchicine dose-reduced or avoided
On anticoagulantsHigher risk of haemopericardium; consider admission; review the need for anticoagulation
Suspected TB or purulent pericarditisAdmit; specialist and infectious diseases input; purulent pericarditis needs drainage and IV antibiotics

4. Myocarditis ★★★☆

Myocarditis is inflammation of the heart muscle. Presentations range from chest pain with a troponin rise and normal LV function, through new heart failure or arrhythmia, to fulminant cardiogenic shock and sudden death. It is a recognised cause of sudden cardiac death in young athletes. The 2025 ESC guideline recommends that patients with suspected myocarditis be admitted for assessment and monitoring.1

4.1 Causes, including drugs and vaccines ★★★☆

Table 7. Causes of myocarditis relevant to general practice
CauseKey points
Viral (most common)Parvovirus B19, HHV-6, enteroviruses, influenza, SARS-CoV-2; preceding flu-like or GI illness
mRNA COVID-19 vaccinesRare; mostly young males, within days of a dose (usually the second); usually mild with rapid recovery. Present with chest pain, breathlessness or palpitations. Follow the Australian Immunisation Handbook for further doses9
ClozapineUsually in the first 4 weeks. Australian practice: troponin and CRP at baseline and weekly for the first 4 weeks, with clinical review for fever, tachycardia, chest pain or breathlessness. Rising troponin or CRP: stop clozapine and seek urgent cardiology advice10
Immune checkpoint inhibitorsOften early in treatment; can be fulminant; urgent oncology and cardiology liaison
OtherAutoimmune disease, sarcoidosis, giant cell myocarditis, eosinophilic (drug hypersensitivity), toxins (cocaine, methamphetamine), acute rheumatic fever

4.2 Diagnosis ★★☆☆

Suspect myocarditis in chest pain with a troponin rise and normal coronary arteries (or a young patient without risk factors), unexplained new heart failure, or new arrhythmia after a viral illness. The ECG may show ST elevation, T-wave inversion, conduction block or arrhythmia. Echocardiography assesses LV function. Cardiac MRI is the key non-invasive test (Lake Louise criteria: oedema plus non-ischaemic late gadolinium enhancement). Endomyocardial biopsy is reserved for severe or unexplained cases. Coronary assessment is often needed to exclude MI.1

4.3 Management and return to exercise ★★★☆

  • Hospital assessment for all suspected myocarditis; fulminant cases need intensive care and mechanical support.
  • Heart failure therapy if LV function is reduced (Lesson 4); arrhythmia management; avoid NSAIDs when LV function is impaired.
  • Immunosuppression only for specific types (giant cell, eosinophilic, sarcoid, checkpoint inhibitor), under specialists.
  • Follow-up at 1–3 months with repeat imaging to confirm recovery.
Table 8. Return to exercise after pericarditis or myocarditis (2025 ESC approach)
ConditionAdvice
All formsInitial restriction from strenuous and competitive exercise, about 1 month, then an individualised decision
Uncomplicated pericarditisReturn once symptoms have resolved and CRP is normal; often within weeks in non-athletes
Myocarditis or myopericarditisReturn only when symptoms, troponin and CRP have normalised, LV function has recovered, and there are no arrhythmias on Holter and exercise testing; longer restriction with extensive scar or reduced LVEF
Competitive athletesSpecialist (sports cardiology) assessment before return

Source: 2025 ESC guideline. Older guidance used fixed periods (3 months for pericarditis and 3–6 months for myocarditis in athletes).1,2

5. Pericardial effusion and tamponade ★★★★

5.1 Pericardial effusion ★★★☆

Effusions are found incidentally on echo or CT, or present with breathlessness and chest fullness. The rate of accumulation matters more than size: a slowly accumulating litre may be tolerated, while 150 mL of rapid bleeding can cause tamponade. Causes are those of pericarditis plus malignancy, hypothyroidism, kidney failure, heart failure, post-surgery and trauma.

Table 9. Pericardial effusion: size and approach
Echo size (diastolic)Approach
Small (<10 mm)If asymptomatic, CRP normal and no cause found: usually no treatment and no routine follow-up
Moderate (10–20 mm)Look for a cause (TSH, UEC, CRP, cancer screen as indicated); repeat echo (e.g. at 6 months)
Large (>20 mm)Specialist referral; admit if symptomatic, inflammatory or rising; drainage if tamponade, suspected bacterial or neoplastic cause, or persistent symptoms

Do not treat an effusion with NSAIDs or colchicine unless there is evidence of inflammation (raised CRP, pericarditis).2

5.2 Cardiac tamponade ★★★★

Tamponade is a clinical diagnosis confirmed by echocardiography: the effusion raises intrapericardial pressure until the right heart cannot fill. Look for tachycardia, hypotension, raised JVP, muffled heart sounds (Beck’s triad, often incomplete) and pulsus paradoxus (an inspiratory fall in systolic BP of more than 10 mmHg). The ECG may show low voltage and electrical alternans. Breathlessness with clear lungs is characteristic.

Tamponade: emergency
  • Call 000 or the retrieval service; urgent echocardiography and pericardiocentesis (echo-guided) or surgical drainage.
  • While waiting: oxygen if hypoxic, IV access, a cautious fluid bolus if hypotensive and hypovolaemic.
  • Avoid diuretics, nitrates and other vasodilators (they reduce filling), and avoid positive-pressure ventilation before drainage if possible.
  • Do not give anticoagulants; reconsider existing ones (haemopericardium).
Figure 3. Approach to pericardial effusion.2

6. Constrictive pericarditis ★★★☆

A thickened, often calcified pericardium stops the ventricles filling in diastole. The patient presents over months with fatigue, oedema, ascites out of proportion to peripheral oedema and a large liver, and is often first investigated for liver disease. Signs: very raised JVP with a rapid y descent, Kussmaul’s sign (JVP rises on inspiration), a pericardial knock, and AF. Causes include previous viral pericarditis, cardiac surgery, chest radiotherapy and tuberculosis.

Table 10. Constrictive pericarditis versus restrictive cardiomyopathy
FeatureConstrictive pericarditisRestrictive cardiomyopathy
HistoryPrevious pericarditis, surgery, radiotherapy, TBAmyloid, sarcoid, haemochromatosis
PericardiumThickened or calcified (CT, MRI, X-ray)Normal
Natriuretic peptidesNormal or mildly raisedMarkedly raised
EchoSeptal bounce, respiratory variation in filling, normal wall thicknessThick walls (amyloid), biatrial enlargement, reduced tissue velocities
TreatmentPericardiectomy (curative in many); diuretics meanwhileTreat the cause; heart failure care

The first investigation is transthoracic echocardiography, followed by cardiac CT or MRI and, if needed, cardiac catheterisation. Transient constriction after acute pericarditis can resolve with anti-inflammatory treatment.1,2

7. Special populations and rural practice ★★☆☆

  • Aboriginal and Torres Strait Islander people: higher rates of tuberculosis, rheumatic fever (which can cause pericarditis as part of carditis) and kidney failure. Consider these causes, especially with fever or a subacute course.
  • Migrants and refugees from TB-endemic countries: tuberculous pericarditis is a leading cause of large effusions and constriction worldwide.
  • Young people with chest pain after a viral illness or mRNA vaccine: ECG and troponin before reassurance.
  • People taking clozapine: the GP may be the first to see fever, tachycardia or chest pain in the first month; check troponin and CRP the same day.
  • Rural and remote: point-of-care ultrasound may detect effusion; tamponade needs early retrieval. Arrange echocardiography and follow-up in advance for outpatient pericarditis.

8. Old versus new guidance ★★★★

Table 11. Pericarditis and myocarditis: superseded and current teaching
TopicOld teachingCurrent
FrameworkSeparate diseases (2015 ESC pericardial guideline)One spectrum: inflammatory myopericardial syndrome (2025 ESC)
ColchicineFor recurrences onlyFirst episode, 3 months; recurrences, at least 6 months; dose by weight
SteroidsFirst-line optionSecond line, low to moderate dose, slow taper
Refractory recurrenceLong-term steroidsIL-1 inhibitors (anakinra, rilonacept) when CRP is raised
ExerciseFixed bans (3–6 months)Initial restriction (about 1 month), then individualised
Myocarditis imagingEndomyocardial biopsyCardiac MRI first; biopsy for selected cases
Where candidates lose marks

From the RACGP KFP 2025.1 public exam report6

  • Acute pericarditis on an ECG (young Aboriginal man): the common error was misdiagnosing an acute myocardial infarction, which led to incorrect management.
  • Pharmacological management in that case: some candidates gave two NSAIDs at the same time, which was not indicated. The question was otherwise answered well.
  • Answer technique: give only the number of answers requested and be specific (drug, dose, duration).

Other common traps

  • Leaving colchicine out, or giving it for 2 weeks instead of 3 months.
  • Using ibuprofen early after an MI instead of aspirin.
  • Giving diuretics or GTN to a patient with tamponade.
  • Reassuring a young patient with chest pain after a viral illness without checking troponin.

9. Worked case (KFP style)

Liam O’Connor, aged 27 years, has had 2 days of sharp central chest pain, worse lying flat and on deep breathing, eased by sitting forward. He had a cold a week ago. He weighs 82 kg and has no medical history. Temperature 37.6°C, pulse 96, BP 124/76 mmHg, SpO2 98%. You hear a scratchy sound at the left sternal edge with him leaning forward. ECG: widespread concave ST elevation with PR depression; ST depression and PR elevation in aVR only.

Question 1. What is the most likely diagnosis? Write one answer.

Show answer
  • Acute (idiopathic or viral) pericarditis.

Scores zero: STEMI, ACS, “chest pain”.

Question 2. List up to four investigations you would arrange.

Show answer
  • CRP (and/or ESR).
  • Troponin (high-sensitivity).
  • Transthoracic echocardiography.
  • FBC and UEC (with eGFR) and LFTs.

Also accepted: chest X-ray. Scores zero: coronary angiography, D-dimer without suspicion of PE, viral serology (does not change management).

His troponin is normal, CRP 64 mg/L, echo shows a 6 mm effusion with normal LV function. He has no high-risk features.

Question 3. List his pharmacological management, including doses and durations. List up to three.

Show answer
  • Ibuprofen 600 mg three times daily with food for 1–2 weeks, then taper (or aspirin 750–1000 mg three times daily).
  • Colchicine 500 micrograms twice daily (weight ≥70 kg) for 3 months.
  • A PPI (e.g. pantoprazole 40 mg daily) while on the NSAID.

Scores zero: two NSAIDs together, prednisolone, antibiotics, colchicine for 2 weeks, “anti-inflammatories” without detail.

Question 4. He plays semi-professional football. What advice do you give about sport? Write one answer.

Show answer
  • No strenuous or competitive sport until symptoms have resolved and CRP has normalised (initially about 1 month), then an individualised return after review, with sports cardiology assessment if he competes.

Scores zero: “return when he feels well”, “no restriction”.

10. Self-check questions

These questions are written at or above AKT difficulty. Every option is plausible and the options are deliberately similar. Commit to an answer before revealing the explanation.

⏱ Exam-pace challenge. The AKT gives you 4 hours for 150 questions — about 1.6 minutes each.8 Time yourself: Questions 1–5 in 8 minutes, then 6–10 in 8 minutes. Rate your confidence honestly before you reveal each answer.
Question 1

Ethan Brooks, aged 24 years, has had sharp central chest pain for 36 hours, worse lying down and when breathing in. He had a sore throat last week. Pulse 92, BP 122/74 mmHg, temperature 37.5°C. His ECG shows concave ST elevation in I, II, aVL, aVF and V2–V6, with PR depression in the same leads and PR elevation in aVR. There is no reciprocal ST depression apart from aVR. High-sensitivity troponin I is 4 ng/L at 0 and 2 hours (normal <16). CRP is 48 mg/L. Echo shows normal LV function and a small effusion.

What is the MOST likely diagnosis?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: E. Idiopathic pericarditis

Feedback: This question requires candidates to separate pericarditis from its mimics using the ECG and troponin together. Pleuritic, positional pain after a viral illness, widespread concave ST elevation with PR depression, no reciprocal change outside aVR, raised CRP and a small effusion meet the diagnostic criteria. The normal serial troponin means there is no myocardial involvement.

  • Acute myopericarditis: requires a troponin rise; his serial troponin is normal.
  • Acute pulmonary embolism: does not cause widespread ST elevation with PR depression; normal SpO2 and heart rate pattern do not suggest it.
  • Anterior occlusion MI: ST elevation would be in one territory with reciprocal depression and a troponin rise.
  • Benign early repolarisation: asymptomatic, no PR depression, no raised CRP or effusion.
  • Takotsubo stress syndrome: postmenopausal women after stress, with troponin rise and apical ballooning.
  • Type 1 Brugada pattern: coved ST elevation in V1–V2 only, with no pain syndrome.
  • Type A aortic dissection: sudden tearing pain, pulse differences; no PR depression pattern.

Reference: ESC myocarditis and pericarditis guideline 2025.

Got this wrong? Re-read 3.2 Diagnosis and the ECG →

Question 2

Chloe Martin, aged 31 years, has a first episode of acute idiopathic pericarditis with no high-risk features. She weighs 62 kg, has normal kidney and liver function, and takes no regular medicines. You start ibuprofen 600 mg three times daily and pantoprazole.

What is the MOST appropriate colchicine regimen?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: B. Colchicine 500 micrograms daily for 3 months

Feedback: This question requires candidates to combine two facts: weight-based dosing (once daily under 70 kg, twice daily at 70 kg or more) and duration by episode (3 months for a first episode, at least 6 months for recurrence). At 62 kg with a first episode, she needs 500 micrograms once daily for 3 months.

  • Colchicine 500 micrograms daily for 2 weeks: too short; the recurrence benefit comes from a 3-month course.
  • Colchicine 500 micrograms daily for 6 months: the duration for recurrent pericarditis.
  • Colchicine 500 micrograms twice daily for 3 months: the dose for patients weighing 70 kg or more.
  • Colchicine 500 micrograms twice daily for 6 months: recurrence regimen for a heavier patient.

Reference: ESC myocarditis and pericarditis guideline 2025; ICAP trial.

Got this wrong? Re-read 3.4 Treatment →

Question 3

Nikhil Sharma, aged 46 years, has had 10 days of gradually worsening pleuritic chest pain and night sweats. Temperature 38.4°C, pulse 104, BP 118/74 mmHg, SpO2 97%. JVP is not raised. His ECG shows widespread concave ST elevation. A bedside echo at a nearby clinic reported a 22 mm circumferential effusion without chamber collapse. CRP 140 mg/L, troponin normal. He migrated from India 2 years ago.

What is the MOST appropriate next step?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: B. Refer to the emergency department for admission

Feedback: This question requires candidates to recognise major high-risk features that rule out outpatient management. He has three: fever above 38°C, subacute onset, and a large effusion (>20 mm). With night sweats and migration from a TB-endemic country, tuberculous or purulent pericarditis must be excluded; he needs admission, investigation of the cause and possibly pericardiocentesis.

  • Arrange outpatient echocardiogram within 2 weeks: a large effusion with fever needs same-day assessment.
  • Repeat ECG and CRP in 48 hours before treating: delays care in a high-risk patient.
  • Start ibuprofen and colchicine; review in 1 week: correct only for low-risk pericarditis.
  • Start prednisolone 1 mg/kg and review in 1 week: steroids could worsen tuberculous or bacterial infection and are second line.

Reference: ESC pericardial guidelines 2015 and 2025.

Got this wrong? Re-read 3.3 Who can be managed at home? →

Question 4

Sarah Kim, aged 38 years, weighs 74 kg. Four months ago she had acute idiopathic pericarditis. She took ibuprofen for 2 weeks and stopped colchicine after 3 weeks because she felt well. She was symptom-free for 10 weeks, but now has the same pleuritic pain with a rub, widespread ST elevation and CRP 52 mg/L. Echo shows a small effusion and normal LV function. She has no high-risk features.

What is the MOST appropriate treatment?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: D. NSAID plus colchicine for at least 6 months

Feedback: This question requires candidates to recognise a recurrence (symptom-free interval of more than 4–6 weeks) caused by inadequate first treatment, and to choose the recurrence regimen. An NSAID (tapered once CRP normalises) plus colchicine at the weight-based dose (twice daily at 74 kg) for at least 6 months is standard.

  • Anakinra, after referral to a cardiologist: for recurrences that fail colchicine and NSAIDs, or steroid dependence; she has never completed standard therapy.
  • NSAID alone for 2 weeks, then taper: omitting colchicine is what caused this recurrence.
  • NSAID plus colchicine for 3 months only: the first-episode duration.
  • Prednisolone 1 mg/kg daily for 4 weeks: high-dose steroids increase further recurrences and are second line.

Reference: ESC myocarditis and pericarditis guideline 2025.

Got this wrong? Re-read 3.5 Recurrent pericarditis →

Question 5

Joseph Mabior, aged 58 years, has 8 months of increasing abdominal swelling, ankle oedema and fatigue. He was treated for pulmonary tuberculosis in Sudan 10 years ago. He drinks no alcohol. His JVP is raised to the earlobe and rises further on inspiration; there is an early diastolic sound, a large liver, marked ascites and mild ankle oedema. LFTs show mildly raised bilirubin and ALP; albumin 34 g/L. Hepatitis B and C serology are negative.

What is the MOST appropriate initial investigation?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: E. Transthoracic echocardiography

Feedback: This question requires candidates to recognise constrictive pericarditis presenting as “liver disease” and to choose the first test. Ascites out of proportion to oedema, a very high JVP with Kussmaul’s sign, a pericardial knock and previous TB point to constriction. Echocardiography is the first-line test (septal bounce, respiratory variation, pericardial thickening) and also assesses for restrictive cardiomyopathy.

  • Abdominal ultrasound with liver Doppler: would show hepatic congestion but not the cause; a raised JVP is never explained by liver disease.
  • Cardiac MRI with gadolinium contrast: useful for confirmation and pericardial inflammation, but after echocardiography.
  • Contrast CT of the abdomen and pelvis: looks in the wrong place; chest CT (for pericardial calcification) would come after echo.
  • Diagnostic ascitic tap with SAAG: a high SAAG with high protein would suggest a cardiac cause but does not diagnose constriction.

Reference: ESC pericardial guidelines 2015 and 2025.

Got this wrong? Re-read 6. Constrictive pericarditis →

Question 6

Mavis Clarke, aged 67 years, has metastatic lung cancer. She is brought to your rural hospital with 2 days of worsening breathlessness. Pulse 124, BP 86/64 mmHg, respiratory rate 26, SpO2 95%. Her JVP is raised, heart sounds are soft, and her lungs are clear. Systolic BP falls by 18 mmHg on inspiration. Point-of-care ultrasound shows a large pericardial effusion with right ventricular diastolic collapse. The retrieval team and a cardiologist are on the phone.

What is the MOST appropriate definitive management?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: A. Echo-guided pericardiocentesis without delay

Feedback: This question requires candidates to recognise tamponade (hypotension, tachycardia, raised JVP, soft heart sounds, clear lungs, pulsus paradoxus of 18 mmHg, RV diastolic collapse) and to know that drainage is the only definitive treatment. Every other option reduces preload or removes a compensatory mechanism and can precipitate cardiac arrest.

  • GTN infusion to reduce preload and pain: venodilators reduce filling and can cause collapse.
  • Intubation and positive pressure ventilation: raises intrathoracic pressure, further reducing venous return; avoid before drainage if possible.
  • IV furosemide 40 mg to offload the RV: diuresis reduces preload; the raised JVP reflects compression, not fluid overload.
  • IV metoprolol to slow the sinus tachycardia: the tachycardia maintains cardiac output; slowing it can be fatal.

Reference: ESC pericardial guidelines 2015 and 2025.

Got this wrong? Re-read 5.2 Cardiac tamponade →

Question 7

Brian Hughes, aged 63 years, had an anterior STEMI treated with primary PCI 3 days ago and is still in hospital. He takes aspirin 100 mg, ticagrelor 90 mg twice daily, atorvastatin 80 mg, ramipril and bisoprolol. He develops sharp pleuritic chest pain relieved by sitting forward, and a rub. The ECG shows no new ischaemic changes, echo shows a small effusion and stable LV function, and repeat angiography is not needed.

What is the MOST appropriate anti-inflammatory treatment?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: A. High-dose aspirin; continue ticagrelor

Feedback: This question requires candidates to manage early post-infarction pericarditis. Aspirin is the anti-inflammatory of choice after an MI; other NSAIDs and corticosteroids may impair infarct healing and increase the risk of rupture and further events. DAPT must not be interrupted after a fresh stent. Colchicine may be added.

  • Ibuprofen 600 mg three times daily: non-aspirin NSAIDs are avoided early after MI; ibuprofen also interferes with aspirin’s antiplatelet effect.
  • Indomethacin 25 mg three times daily: particularly avoided after MI (reduces coronary flow).
  • Prednisolone 25 mg daily, then taper: steroids impair scar healing and increase recurrence.
  • Stop ticagrelor and start ibuprofen: stopping a P2Y12 inhibitor 3 days after a stent risks stent thrombosis.

Reference: ESC pericardial guidelines 2015 and 2025.

Got this wrong? Re-read 3.6 Special situations →

Question 8

Tom Wilkinson, aged 29 years, has treatment-resistant schizophrenia. He started clozapine 19 days ago and is on 200 mg daily. His mother brings him in because he has had a fever and tiredness for 2 days. Temperature 38.1°C, pulse 124 (it was 90 last week), BP 112/70 mmHg. Monitoring bloods taken this morning:

TestLast weekTodayNormal range
Troponin I (hs)5 ng/L62 ng/L*<16
CRP8 mg/L118 mg/L*<5
Neutrophils4.85.62.0–7.5 ×109/L

What is the MOST appropriate next step?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: D. Stop clozapine and arrange same-day hospital review

Feedback: This question requires candidates to recognise probable clozapine-induced myocarditis and act on it. It typically occurs in the first 4 weeks. Fever, a new tachycardia, a troponin more than twice the upper limit and a CRP above 100 mg/L meet the criteria in the Australian monitoring protocol for stopping clozapine. Suspected myocarditis needs hospital assessment (ECG, echo, monitoring), with the psychiatry team informed.

  • Continue clozapine and repeat troponin in 1 week: continuing the drug risks fulminant myocarditis and death.
  • Continue clozapine and start oral metoprolol: treats the heart rate, not the cause.
  • Halve the clozapine dose and recheck CRP in 3 days: dose reduction is an option only for a mild CRP rise without troponin rise.
  • Stop clozapine and recheck troponin in 1 week: stopping is right, but myocarditis needs same-day assessment.

Reference: Ronaldson KJ, et al. ANZJP 2011 (clozapine myocarditis monitoring protocol); ESC myocarditis and pericarditis guideline 2025.

Got this wrong? Re-read 4.1 Causes of myocarditis →

Question 9

Rosa Pereira, aged 70 years, has breast cancer and a known moderate pericardial effusion. She is breathless. You measure her BP with a manual sphygmomanometer during quiet breathing. Korotkoff sounds first appear at 128 mmHg, during expiration only. They are heard throughout the respiratory cycle from 112 mmHg.

What is the MOST appropriate interpretation?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: E. Pulsus paradoxus; difference exceeds 10 mmHg

Feedback: This question requires candidates to measure and interpret pulsus paradoxus. The difference between the first Korotkoff sound (expiration only) and sounds heard throughout respiration is 16 mmHg, more than the 10 mmHg threshold. With a known effusion and breathlessness, this suggests tamponade and needs urgent echocardiography.

  • Kussmaul sign; suggests constrictive pericarditis: Kussmaul’s sign is a rise in JVP on inspiration, not a BP finding.
  • Normal variation; difference is under 20 mmHg: the normal inspiratory fall is up to 10 mmHg, not 20.
  • Pulsus alternans; suggests severe LV failure: alternating strong and weak beats regardless of respiration.
  • Pulsus bisferiens; suggests aortic regurgitation: a double-peaked pulse (AR, HCM), unrelated to respiration.

Reference: ESC pericardial guideline 2015; Rahman A, Saraswat A. AFP 2017.

Got this wrong? Re-read 5.2 Cardiac tamponade →

Question 10

Gordon Ellis, aged 61 years, had an echocardiogram for a murmur, which was mild aortic sclerosis. It also showed a small circumferential pericardial effusion (6 mm in diastole) with no haemodynamic effect. He has no symptoms, no history of chest pain, cancer, kidney disease or recent illness, and a normal examination. CRP, TSH, UEC and FBC are normal, and a chest X-ray is clear.

What is the MOST appropriate management?

How sure are you?
Show answer

You were sure, but wrong. Confident errors are the most dangerous kind, because they never get revised. Re-read the section below today.

Right, but you guessed. Treat this as not yet learnt.

Sure and right — this one is secure.

Answer: C. No treatment or routine follow-up is needed

Feedback: This question requires candidates to show restraint with an incidental small effusion. A small (<10 mm), asymptomatic effusion with normal CRP and no identified cause after basic tests has an excellent prognosis and needs no treatment or routine follow-up. Advise him to return if he develops symptoms.

  • Colchicine 500 micrograms daily for 3 months: anti-inflammatory treatment is only for inflammatory effusions (raised CRP or pericarditis).
  • Ibuprofen 400 mg three times daily for 2 weeks: same reason; adds GI and kidney risk for no benefit.
  • Refer for diagnostic pericardiocentesis: for tamponade or suspected bacterial or malignant effusions, not a small idiopathic one.
  • Repeat echocardiogram every 3 months for 1 year: surveillance is for moderate or large effusions.

Reference: ESC pericardial guideline 2015.

Got this wrong? Re-read 5.1 Pericardial effusion →

Self-check score: / 10

Sure but wrong:

Any “sure but wrong” answer is your highest exam risk. Re-read those sections first, then use the flashcards at the end of the lesson. Your selections are not saved; the score resets when you leave the page.

Exam-readiness check

Tick each one you can do without notes. Anything left unticked is your revision list.

Ready on of 8.

11. Key takeaways

Remember for the exam
  • Diagnosis: two of four: typical pain, rub, widespread ST elevation/PR depression, new effusion. Support: raised CRP.
  • ECG: concave, widespread ST elevation with PR depression; no reciprocal change except aVR and V1.
  • Admit if: fever >38°C, subacute onset, effusion >20 mm, tamponade, NSAID failure at 1 week; consider if troponin raised, immunosuppressed, trauma, anticoagulated.
  • Treatment: ibuprofen 600 mg tds or aspirin 750–1000 mg tds for 1–2 weeks then taper + colchicine 500 micrograms daily (<70 kg) or twice daily (≥70 kg) for 3 months + PPI.
  • Recurrence: NSAID + colchicine for at least 6 months; IL-1 inhibitors for refractory cases with raised CRP; steroids second line.
  • Post-MI: aspirin, not other NSAIDs or steroids; continue DAPT.
  • Pregnancy: NSAIDs until 20 weeks; low-dose prednisolone later; ibuprofen OK when breastfeeding. Children: no aspirin.
  • Myocarditis: admit; cardiac MRI; clozapine myocarditis in the first 4 weeks (weekly troponin and CRP); mRNA vaccine myocarditis mostly in young males.
  • Exercise: initial restriction (about 1 month), then individualised return (2025 ESC).
  • Tamponade: pulsus paradoxus >10 mmHg, Beck’s triad, clear lungs; drain; avoid diuretics, nitrates, beta-blockers and positive pressure ventilation.
  • Constriction: ascites out of proportion, Kussmaul’s sign, knock; echo first; pericardiectomy.

Your revision plan

Spaced revision for this lesson
WhenWhat to do
TodayFinish the lesson, both question sets and the readiness checklist. Note every “sure but wrong” answer.
Day 3Do this lesson’s 10 flashcards again (end of this lesson). Re-read every section you marked “Not yet”.
Day 7Redo the self-check questions without looking at the lesson. Aim for 8/10 with no “sure but wrong”.
Day 21Do the cardiovascular chapter flashcard deck, then one timed block of mixed questions at exam pace.
Week before the examRe-read the key takeaways, Figure 1 and the old-notes box. Do the chapter flashcard deck once more.

Your next step

Use your scores from the cold-start check and the self-check questions to choose your next step.

Self-check under 6/10, or any “sure but wrong”: your knowledge has gaps you may not have noticed. Start the flashcards for this lesson today and re-read the sections you missed.This lesson’s 10 flashcards
6–8/10: the knowledge is there but not yet secure. Do the flashcards daily for a week, then redo the self-check.Start the flashcards
9–10/10 with no confident errors: move on to the next lesson and keep this topic fresh with the full chapter deck once a week.Cardiovascular chapter deck

Flashcards: 10 high-yield recall cards

Finish the lesson by testing your recall. Say the answer out loud before you tap the card to flip it, then mark “I knew this” only if you were fully right without looking. Repeat the cards on day 3 and day 21, and use the cardiovascular chapter deck for later reviews.

Card 1 of 10 · Section 3.2

← Previous

Card 2 of 10 · Section 3.2

Card 3 of 10 · Section 3.3

Card 4 of 10 · Section 3.4

Card 5 of 10 · Section 3.4

Card 6 of 10 · Section 3.6

Card 7 of 10 · Section 3.6

Card 8 of 10 · Section 4.1

Card 9 of 10 · Section 5.2

Card 10 of 10 · Section 6

Knew it: / 10 known

12. References and recommended reading

References

  1. Schulz-Menger J, Imazio M, Collini V, et al. 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur Heart J 2025. doi:10.1093/eurheartj/ehaf192.
  2. Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Eur Heart J 2015;36:2921–64.
  3. Rahman A, Saraswat A. Pericarditis. Aust Fam Physician 2017;46(11). racgp.org.au (accessed 10 Nov 2026).
  4. Therapeutic Guidelines. Cardiovascular (current version): pericarditis. Melbourne: Therapeutic Guidelines Limited. tg.org.au (accessed 10 Nov 2026).
  5. Australian Medicines Handbook. Adelaide: AMH Pty Ltd (current edition): colchicine; NSAIDs. amhonline.amh.net.au (accessed 10 Nov 2026).
  6. The Royal Australian College of General Practitioners. KFP 2025.1 public exam report. Melbourne: RACGP; 2025. racgp.org.au (accessed 10 Nov 2026).
  7. The Royal Australian College of General Practitioners. AKT 2026.2 public exam report (lists pericarditis among examined cardiovascular topics). Melbourne: RACGP; 2026. racgp.org.au (accessed 10 Nov 2026).
  8. The Royal Australian College of General Practitioners. AKT and KFP: general exam delivery information. racgp.org.au (accessed 10 Nov 2026).
  9. Australian Technical Advisory Group on Immunisation. Australian Immunisation Handbook: COVID-19 (myocarditis and pericarditis after mRNA vaccines). immunisationhandbook.health.gov.au (accessed 10 Nov 2026).
  10. Ronaldson KJ, Fitzgerald PB, Taylor AJ, et al. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry 2011;45:458–65.
  11. Imazio M, Brucato A, Cemin R, et al (ICAP). A randomized trial of colchicine for acute pericarditis. N Engl J Med 2013;369:1522–8.
  12. Klein AL, Imazio M, Cremer P, et al (RHAPSODY). Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis. N Engl J Med 2021;384:31–41.

Recommended reading for RACGP fellowship candidates

  • 2025 ESC myocarditis and pericarditis guideline — the current framework, including return to exercise.
  • Rahman and Saraswat, “Pericarditis”, AFP 2017 — a short Australian general practice review with a worked case.
  • Therapeutic Guidelines: Cardiovascular and AMH — Australian doses for NSAIDs and colchicine, and colchicine interactions.
  • Australian Immunisation Handbook — vaccine-associated myocarditis advice.
  • Murtagh’s General Practice (chest pain chapter); RACGP check and AJGP; RACGP curriculum: cardiovascular health.

Version history

VersionDateChanges
2026–27 (v1.0)10 Nov 2026First edition, with engagement layer, study-priority stars and end-of-lesson flashcards. Based on the 2025 ESC myocarditis and pericarditis guideline, the 2015 ESC pericardial guideline, Therapeutic Guidelines and AFP 2017.

© GP Institute of Australia. For educational use by enrolled candidates only; not for redistribution. This lesson summarises current guidelines for exam preparation and does not replace current clinical guidelines or clinical judgement. Always check doses in current Therapeutic Guidelines and AMH.

Sorry, You cannot copy contents of this page.

If you are trying to login, please use the right click to enter you details!

Scroll to Top